Biotechnology Assets, S.A. (BME:BST)
Spain · Delayed Price · Currency is EUR 0.3550
-0.0010 (-0.28%)
Oct 28, 2025, 12:54 PM CET
Biotechnology Assets Market Cap
Biotechnology Assets has a market cap or net worth of €24.31 million as of October 28, 2025. Its market cap has increased by 25.55% in one year.
Market Cap
24.31M
Enterprise Value
26.14M
Revenue
2.97M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.36
Market Cap Chart
Since May 29, 2018, Biotechnology Assets's market cap has decreased from 74.66M to 24.31M, a decrease of -67.43%. That is a compound annual growth rate of -14.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 24.31M | 33.01% |
| Dec 31, 2024 | 18.28M | -20.03% |
| Dec 29, 2023 | 22.86M | 84.02% |
| Dec 30, 2022 | 12.42M | -40.67% |
| Dec 30, 2021 | 20.94M | -3.86% |
| Dec 31, 2020 | 21.78M | -72.86% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.89B |
| Laboratorios Farmaceuticos Rovi | 3.29B |
| Almirall | 2.71B |
| Faes Farma | 1.40B |
| Pharma Mar | 1.28B |
| Clínica Baviera | 722.75M |
| Atrys Health | 256.45M |
| Oryzon Genomics | 252.72M |